Health Condition 1: I10- Essential (primary) hypertension
Conditions
Interventions
Intervention1: NIA/DG/2020/01 - trial drug of study
: Dose- 2 capsules twice a day
Anupana- Lukewarm water
Route of administration- Oral
Time of administration- Before meal
Duration of therapy- 90 day
Sponsors
National Institute of Ayurveda
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients belonging to either sex between the age group 18 to 60 years. 2. Patients of Stage 1 Primary Hypertension. 3. Mild to moderate grade patients of hypertension as per 8th JNC & WHO criteria will be included. 4. Isolated grade-1 systolic or diastolic hypertension.
Exclusion criteria
Exclusion criteria: 1. Known cases of Secondary hypertension. 2. Known cases of Renal diseases, Diabetic Mellitus. 3. Known cases of Pregnancy induced hypertension. 4. Known cases of Ventricular hypertrophy, coarctation of aorta. 5. Known cases of Portal hypertension. 6. Known cases of Renal artery stenosis induced hypertension. 7. Patients using other antihypertensive medicines of conventional biomedicine / AYUSH systems / any other system. 8. Patients using drugs like Oral Contraceptive Pills, steroids. 9. Patient not taking any previous anti-hypertensive medication. 10. Patient with no evidence of any target organ damage.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in Blood PressureTimepoint: Reduction in blood pressure after 2 weeks, 4 weeks, 6 weeks, 8 weeks, 10 weeks, 12 weeks. | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in Sign and symptom (Subjective Criteria) Changes in Objective Criteria like DLC, Platelet count, SGOT, SGPT & S. Creatinine.Timepoint: 3 months follow up 1 month | — |
Countries
India
Contacts
Public ContactDr Swati Goyal
National Institute of Ayurveda
Outcome results
None listed